The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Inspections

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive mock FDA inspection services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Inspections

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Team of nerdy entrepreneurs reading confusing reports in the office.

    Layoff and RIFs Raise Question for Moving Forward

    April Fool’s Day was a difficult day for many FDA employees, because...
    Read More
    Bx Rating - Lachman Blog

    FDA Issues Notice to Pharmaceutical Companies Regarding the CRO Raptim Research Pvt. Ltd.

    On March 28, the FDA issued a notice (here) informing pharmaceutical c...
    Read More
    Tariffs - What It Means for Pharmaceuticals and Beyond - Lachman Blog

    New Administration Doubles Down on Tariffs: What It Means for Pharmaceuticals and Beyond

    President Donald Trump has reaffirmed his commitment to imposing tarif...
    Read More
    What’s a Body to Do - Lachman Blog

    What’s a Body to Do?

    Now that Dr. Marty Makary, MD, MPH, has been confirmed and appointed a...
    Read More
    Data Ownership - Lachman Blog

    Data Ownership: Whose Asset? Whose Data?

    The recent bankruptcy announcement of 23andMe is a classic case study ...
    Read More
    VHP Revisited 2025 - Lachman Blog

    Vapour Hydrogen Peroxide, Still Fragile? A Retrospective Follow-Up on a 2018 MHRA Blog

    In April 2018, whilst I was still an expert Inspector at the MHRA, I w...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today